Discover 214 paid clinical trials in Montana. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Whether you’re looking to join as a healthy volunteer in a paid clinical trial or need condition-specific options, Montana has a wide range of research opportunities to suit. Active recruitment is underway at research centers in Billings, Missoula, and Great Falls, allowing participants to access advanced treatments and high-quality medical care.
Filter
1
Filter results
Results: 214
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
for
Breast Cancer
Location: Westbury NY, New York NY, Midlothian VA, Plantation FL,
Location: Quebec, Bethesda MD, Richmond VA, West Palm Beach FL,
Sponsor: Loxo Oncology, Inc.
Sex: All
Age: 18+
Code: NCT05254743
Phase 3, Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
for
Prostate Cancer (Adenocarcinoma)
Location: Saint John, Providence RI, Saint Johnsbury VT,
Sponsor: Canadian Cancer Trials Group
Sex: Male
Age: 18+
Code: NCT06592924
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
for
Recurrent Non-Muscle Invasive Bladder Carcinoma,
Location: Peabody MA, Boston MA, Burlington MA, Commack NY,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT07000084
Phase 3, Recruiting
Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer
for
Non-Small Cell Lung Cancer
Location: Boston MA, Philadelphia PA, Arlington VA, Fairfield OH,
Sponsor: BicycleTx Limited
Sex: All
Age: 18+
Code: NCT06933329
Phase 2, Recruiting
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
for
RSV Infection
Location: Boston MA, Norfolk VA, Richmond VA,
Sponsor: Pfizer
Sex: All
Age: 0+
Code: NCT06866405
Phase 3, Recruiting
A Study of Dotinurad Versus Allopurinol in Participants With Gout
for
Gout
Location: Waltham MA, West Long Branch NJ, Brooklyn NY,
Sponsor: Crystalys Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07089875
Phase 3, Recruiting
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
for
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements,
Location: Guilford CT, New Haven CT, Derby CT, Burlington VT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06649812
Phase 2, Recruiting
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
for
Tophaceous Gout
Location: Waltham MA, West Long Branch NJ, Brooklyn NY,
Sponsor: Crystalys Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07089888
Phase 3, Recruiting
Integrated Cancer Repository for Cancer Research
for
Pancreatic Cancer, Thyroid Cancer, Lung Cancer,
Location: Manchester CT, Holyoke MA, Glens Falls NY, Utica NY,
Sponsor: University of Nebraska
Sex: All
Age: 19 - 70+
Code: NCT02012699
Recruiting
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Location: Saint John, Portland ME, Providence RI, Worcester MA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06679101
Phase 3, Recruiting
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
for
Lymphoma, Large B-Cell, Diffuse
Location: Boston MA, Westbury NY, Mineola NY, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06890884
Phase 2, Recruiting
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
for
Head and Neck Squamous Cell Carcinoma,
Location: Damariscotta ME, Bath ME, Augusta ME, Brunswick ME,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06992427
Phase 3, Recruiting
Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors
for
Cancer-related Fatigue, Breast Cancer, Prostate Cancer
Location: Aurora CO, Missoula MT
Sponsor: University of Colorado, Denver
Sex: All
Age: 18 - 70+
Code: NCT07001241
Phase 2, Recruiting
Diagnosing Epilepsy To EffeCT Change
for
Epilepsy, Epilepsy (Treatment Refractory)
Location: Boston MA, New Haven CT, Philadelphia PA, Durham NC,
Sponsor: Epiminder America, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07110337
Recruiting
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Worcester MA, Quebec, White Plains NY, The Bronx NY,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07144280
Phase 3, Recruiting
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
for
Castration-Resistant Prostate Carcinoma,
Location: South Weymouth MA, Foxborough MA, Methuen MA,